🇺🇸 LLY — Eli Lilly and Company

Healthcare Compra
← Volver

Precio actual

1.149,36 USD

Máx. histórico

1.292,65

16 días

Split 2:1 del 16/10/1997

Caída desde máximo

-11,08%

Rango 52 semanas

712,05 – 1.292,65

Variación hoy

-0,88%

Cierre anterior

1.159,60

Rango de hoy

1.138,31 – 1.158,43

Volumen hoy

2.159.931

Información
Nombre completo
Eli Lilly and Company
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
50.000
PER ⓘ
38,61 (puede no estar actualizado)
Dividend yield
0,60% (puede no estar actualizado)
Precio objetivo analistas
1.315,56 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 días
Sobre la empresa

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F. Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.A. for Ebglyss; and Chugai Pharmaceutical Co., Ltd for orforglipron; strategic collaboration with Ascidian Therapeutics for development of therapies for undisclosed monogenic kidney diseases; and BioArctic AB (publ) for new treatment. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Dividendos repartidos Total últimos 12 meses: 6,6900 USD · Yield: 0,58%
Fecha de pago Importe por participación
11/08/2011 0,4900 USD
11/05/2011 0,4900 USD
11/02/2011 0,4900 USD
10/11/2010 0,4900 USD
11/08/2010 0,4900 USD
12/05/2010 0,4900 USD
10/02/2010 0,4900 USD
10/11/2009 0,4900 USD
12/08/2009 0,4900 USD
13/05/2009 0,4900 USD
11/02/2009 0,4900 USD
12/11/2008 0,4700 USD
13/08/2008 0,4700 USD
13/05/2008 0,4700 USD
13/02/2008 0,4700 USD
Splits Registrados en el histórico de precios
Fecha Ratio
16/10/1997 2:1
21/12/1995 2:1
01/05/1989 2:1
30/01/1986 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/10/2007 53,83 54,42 53,30 54,15 +0,86% 2,08% 9.714.200
30/10/2007 53,18 54,10 53,09 53,69 +0,32% 1,90% 5.856.400
29/10/2007 52,71 54,00 52,71 53,52 +1,59% 2,45% 9.798.600
26/10/2007 52,52 52,76 52,03 52,68 +0,48% 1,39% 9.437.100
25/10/2007 52,15 53,01 51,80 52,43 -6,63% 2,32% 22.843.100
24/10/2007 56,50 56,75 55,54 56,15 -1,72% 2,14% 5.975.500
23/10/2007 56,41 57,13 56,11 57,13 +1,87% 1,81% 4.417.300
22/10/2007 55,84 56,57 55,73 56,08 +0,04% 1,50% 5.161.000
19/10/2007 56,41 57,17 55,87 56,06 -1,04% 2,30% 5.634.500
18/10/2007 57,10 57,43 56,28 56,65 -0,53% 2,01% 8.366.700
17/10/2007 57,38 57,81 56,60 56,95 -0,35% 2,11% 6.062.200
16/10/2007 57,94 57,95 56,99 57,15 -1,36% 1,66% 6.512.400
15/10/2007 58,62 58,82 57,83 57,94 -1,01% 1,69% 5.585.000
12/10/2007 58,35 58,78 57,98 58,53 +0,31% 1,37% 2.865.400
11/10/2007 58,42 58,87 58,19 58,35 -0,09% 1,16% 5.115.700
10/10/2007 58,53 58,89 58,20 58,40 -0,26% 1,18% 4.350.000
09/10/2007 58,95 59,18 58,50 58,55 -0,76% 1,15% 4.175.100
08/10/2007 59,27 59,41 58,91 59,00 -0,79% 0,84% 2.690.300
05/10/2007 59,30 59,82 59,15 59,47 +0,86% 1,13% 3.760.800
04/10/2007 58,90 59,42 58,90 58,96 +0,14% 0,88% 4.869.200
03/10/2007 58,05 59,15 57,84 58,88 +0,79% 2,26% 4.101.300
02/10/2007 58,38 58,57 57,96 58,42 +0,22% 1,04% 2.889.400
01/10/2007 57,09 58,50 57,04 58,29 +2,39% 2,56% 5.629.900
28/09/2007 57,18 57,43 56,74 56,93 -0,77% 1,21% 4.329.200
27/09/2007 57,60 57,70 56,84 57,37 -0,05% 1,49% 5.710.400
26/09/2007 57,55 58,01 57,32 57,40 +0,33% 1,20% 5.383.700
25/09/2007 57,27 58,00 56,96 57,21 -0,56% 1,82% 4.537.800
24/09/2007 57,89 58,18 57,26 57,53 -0,16% 1,59% 3.286.500
21/09/2007 57,50 57,95 57,08 57,62 +0,95% 1,51% 4.892.100
20/09/2007 57,53 57,65 57,08 57,08 -0,78% 0,99% 3.676.300